Skip links

CHI: Discovery on Target – Radioligand Therapies, Sep 29-Oct 1, 2026, Boston, US

We are pleased to announce that Randolf Kerschbaumer, CEO of OncoOne, will be attending the Discovery on Target – Radioligand Therapies conference in Boston, taking place from September 29 to October 1, 2026.

On September 30 at 9:35 AM, Randolf will present “Pretargeting Strategies in Radioimmunotherapy”, highlighting OncoOne’s proprietary PreTarg-it platform and its potential to enable next-generation pretargeted radioimmunotherapies.

We look forward to connecting with industry leaders and exchanging ideas on the future of targeted radiopharmaceuticals and precision oncology.

Meet us in Boston!